Parkinson’s Disease Market Landscape 2032

DelveInsight’s latest report, “Parkinson’s Disease Market Insights, Epidemiology, and Market Forecast-2032,” provides a comprehensive analysis of Parkinson’s disease, including historical and forecasted epidemiology, market trends, and treatment practices in key regions such as the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

The Parkinson’s disease market is anticipated to experience substantial growth with a decent Compound Annual Growth Rate (CAGR) by 2032, according to DelveInsight. The market size in the 7 Major Markets (7MM) was approximately USD 3.2 billion in 2022. Notable companies operating in the Parkinson’s disease market include Cerevel Therapeutics, Pfizer, Pharma Two B, AbbVie, Biogen, Denali Therapeutics, Annovis Bio, Amneal Pharmaceuticals, BioVie, Cerevance, Clene Nanomedicine, Intra-Cellular Therapies, Hoffmann-La Roche, Prothena Corporation, and others.

Link to Report: Parkinson’s Disease Market

Key Parkinson’s disease therapies expected to launch in the market include Tavapadon, P2B001, ABBV-951 (foscarbidopa/foslevodopa), BIIB122/DNL151, Buntanetap, IPX203, NE3107, CVN424, CNM-Au8, ITI-214 (lenrispodun), Prasinezumab (RO7046015/RG7935/PRX002), among others.

Parkinson’s Disease Overview: Parkinson’s disease is a degenerative ailment characterized by the loss of nerve cells in the substantia nigra, a brain region that controls movement. While the cause remains unknown, it is hypothesized that environmental risk factors, coupled with a hereditary vulnerability, may contribute. The majority of cases are assumed to be sporadic, with up to 20% of individuals with Parkinson’s disease having a first-degree relative with the condition.

Parkinson’s Disease Market: The report delves into the Parkinson’s disease market outlook, analyzing historical, current, and forecasted trends. It assesses the impact of existing therapies, unmet needs, market drivers, barriers, and the demand for advanced technology. The market data are presented with relevant tables and graphs for a clear overview.

Link to Report: Parkinson’s Disease Market Size

Parkinson’s Disease Epidemiology: Insights into historical and current patient pools, along with forecasted trends for seven major countries, are provided. Segmentation includes diagnosed prevalent population based on gender, age, and disease stage.

Parkinson’s Disease Drugs Uptake: This section focuses on the uptake rate of recently launched or expected Parkinson’s disease drugs from 2019 to 2032, covering market uptake, patient uptake, and drug sales.

Parkinson’s Disease Pipeline Development Activities: The report highlights therapeutic candidates in Phase II and Phase III stages, including key players involved in developing targeted therapeutics.

Parkinson’s Disease Companies involved in developing targeted therapeutics:

  1. Cerevel Therapeutics
  2. Pfizer
  3. Pharma Two B
  4. AbbVie
  5. Biogen
  6. Denali Therapeutics
  7. Annovis Bio
  8. Amneal Pharmaceuticals
  9. BioVie
  10. Cerevance
  11. Clene Nanomedicine
  12. Intra-Cellular Therapies
  13. Hoffmann-La Roche
  14. Prothena Corporation

Parkinson’s Disease Therapeutics Assessment: Major companies working in the Parkinson’s disease therapeutics market to develop novel therapies are listed, driving treatment markets in the upcoming years.

Parkinson’s Disease Report Key Insights: Key insights include patient population, market size and trends, cross-competition, market dynamics, opportunities, therapeutic approaches, pipeline analysis, current treatment practices/algorithm, and the impact of emerging therapies on the market.

The comprehensive report provides valuable information for stakeholders, researchers, and industry players seeking insights into the evolving landscape of Parkinson’s disease. For those interested in a more detailed analysis, a free sample report can be requested here for Parkinson’s disease market report.

DelveInsight is a leading Life Science market research and business consulting company, acknowledged for its syndicated market research reports and customized solutions in the healthcare sector.

Trending Reports:

Healthcare Consulting Service

DelveInsights multidimensional, purposeful, and credible pharma and medtech consulting services will aid in the acceleration of product services, including aspects such as congress intelligence, conference coverage, CI asset/indication tracking, brand presence and penetration assessment, drug therapy uptake, and diagnostic landscape assessment to overcome several market challenges.

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Contact Us:

Ankit Nigam

Assistant Manager Marketing

info@delveinsight.com

+91-9650213330

https://www.delveinsight.com/consulting/conference-coverage-services

Published by DELVEINSIGHT

DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for improving their performances to stay ahead of the competitors.

Leave a comment

Design a site like this with WordPress.com
Get started